Koszty Sprzedaży Zmiana Data
AstraZeneca USD 2.52B 2.73B 2026-06
Cassava Sciences USD 3.96M 1.16M 2025-09
GlaxoSmithKline GBP 2.07B 192M 2026-06
Glaxosmithkline GBP 1.88B 1.6B 2026-03
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Roche Holding CHF 7.85B 630M 2026-06
West Pharmaceutical Services USD 543.1M 5.4M 2026-06